Novo Nordisk A/S has appointed Maziar Mike Doustdar as the new CEO, effective August 7, 2025, succeeding Lars Fruergaard Jørgensen. Doustdar, previously EVP of International Operations, helped double sales to approximately DKK 112 billion in 2024.
AI Assistant
NOVO NORDISK A S
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.